512 related articles for article (PubMed ID: 8024260)
41. Multislice proton magnetic resonance spectroscopic imaging in X-linked adrenoleukodystrophy.
Kruse B; Barker PB; van Zijl PC; Duyn JH; Moonen CT; Moser HW
Ann Neurol; 1994 Oct; 36(4):595-608. PubMed ID: 7944292
[TBL] [Abstract][Full Text] [Related]
42. Glial and axonal changes in systemic lupus erythematosus measured with diffusion of intracellular metabolites.
Ercan E; Magro-Checa C; Valabregue R; Branzoli F; Wood ET; Steup-Beekman GM; Webb AG; Huizinga TW; van Buchem MA; Ronen I
Brain; 2016 May; 139(Pt 5):1447-57. PubMed ID: 26969685
[TBL] [Abstract][Full Text] [Related]
43. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.
Modrego PJ; Fayed N; Pina MA
Am J Psychiatry; 2005 Apr; 162(4):667-75. PubMed ID: 15800137
[TBL] [Abstract][Full Text] [Related]
44. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy.
Davie CA; Wenning GK; Barker GJ; Tofts PS; Kendall BE; Quinn N; McDonald WI; Marsden CD; Miller DH
Ann Neurol; 1995 Feb; 37(2):204-10. PubMed ID: 7847862
[TBL] [Abstract][Full Text] [Related]
45. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus.
Brooks WM; Sabet A; Sibbitt WL; Barker PB; van Zijl PC; Duyn JH; Moonen CT
J Rheumatol; 1997 Dec; 24(12):2323-9. PubMed ID: 9415636
[TBL] [Abstract][Full Text] [Related]
46. Evidence for cellular damage in normal-appearing white matter correlates with injury severity in patients following traumatic brain injury: A magnetic resonance spectroscopy study.
Garnett MR; Blamire AM; Rajagopalan B; Styles P; Cadoux-Hudson TA
Brain; 2000 Jul; 123 ( Pt 7)():1403-9. PubMed ID: 10869052
[TBL] [Abstract][Full Text] [Related]
47. Absolute quantification in proton magnetic resonance spectroscopy is useful to differentiate amnesic mild cognitive impairment from Alzheimer's disease and healthy aging.
Watanabe T; Shiino A; Akiguchi I
Dement Geriatr Cogn Disord; 2010; 30(1):71-7. PubMed ID: 20689286
[TBL] [Abstract][Full Text] [Related]
48. Effects of short-term stress-like cortisol on cerebral metabolism: a proton magnetic resonance spectroscopy study at 3.0 T.
Scheel M; Ströhle A; Bruhn H
J Psychiatr Res; 2010 Jun; 44(8):521-6. PubMed ID: 20022344
[TBL] [Abstract][Full Text] [Related]
49. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.
Bird TD; Stranahan S; Sumi SM; Raskind M
Ann Neurol; 1983 Sep; 14(3):284-93. PubMed ID: 6227276
[TBL] [Abstract][Full Text] [Related]
50. Contribution of proton magnetic resonance spectroscopy to the evaluation of children with unexplained developmental delay.
Martin E; Keller M; Ritter S; Largo RH; Thiel T; Loenneker T
Pediatr Res; 2005 Oct; 58(4):754-60. PubMed ID: 16189205
[TBL] [Abstract][Full Text] [Related]
51. Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo.
Bruhn H; Frahm J; Merboldt KD; Hänicke W; Hanefeld F; Christen HJ; Kruse B; Bauer HJ
Ann Neurol; 1992 Aug; 32(2):140-50. PubMed ID: 1324631
[TBL] [Abstract][Full Text] [Related]
52. Proton MR spectroscopy reveals lactate in infantile neuroaxonal dystrophy (INAD).
Mader I; Krägeloh-Mann I; Seeger U; Bornemann A; Nägele T; Küker W; Grodd W
Neuropediatrics; 2001 Apr; 32(2):97-100. PubMed ID: 11414651
[TBL] [Abstract][Full Text] [Related]
53. Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder.
Deicken RF; Pegues MP; Anzalone S; Feiwell R; Soher B
Am J Psychiatry; 2003 May; 160(5):873-82. PubMed ID: 12727690
[TBL] [Abstract][Full Text] [Related]
54. Brain N-acetylaspartate levels correlate with motor function in metachromatic leukodystrophy.
i Dali C; Hanson LG; Barton NW; Fogh J; Nair N; Lund AM
Neurology; 2010 Nov; 75(21):1896-903. PubMed ID: 21098404
[TBL] [Abstract][Full Text] [Related]
55. 1H and 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders.
van der Knaap MS; van der Grond J; Luyten PR; den Hollander JA; Nauta JJ; Valk J
Ann Neurol; 1992 Feb; 31(2):202-11. PubMed ID: 1575459
[TBL] [Abstract][Full Text] [Related]
56. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia.
Lim KO; Adalsteinsson E; Spielman D; Sullivan EV; Rosenbloom MJ; Pfefferbaum A
Arch Gen Psychiatry; 1998 Apr; 55(4):346-52. PubMed ID: 9554430
[TBL] [Abstract][Full Text] [Related]
57. A comparative study of the different N-acetylaspartate measures of the medial temporal lobe in Alzheimer's disease.
Jessen F; Traeber F; Freymann N; Maier W; Schild HH; Heun R; Block W
Dement Geriatr Cogn Disord; 2005; 20(2-3):178-83. PubMed ID: 16024934
[TBL] [Abstract][Full Text] [Related]
58. Differences in brain metabolism associated with agitation and depression in Alzheimer's disease.
Tsai CF; Hung CW; Lirng JF; Wang SJ; Fuh JL
East Asian Arch Psychiatry; 2013 Sep; 23(3):86-90. PubMed ID: 24088401
[TBL] [Abstract][Full Text] [Related]
59. Increased N-Acetylaspartate/creatine ratio in the medial prefrontal cortex among unmedicated obsessive-compulsive disorder patients.
Fan Q; Tan L; You C; Wang J; Ross CA; Wang X; Zhang T; Li J; Chen K; Xiao Z
Psychiatry Clin Neurosci; 2010 Oct; 64(5):483-90. PubMed ID: 20923427
[TBL] [Abstract][Full Text] [Related]
60. Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging.
Meyerhoff DJ; MacKay S; Bachman L; Poole N; Dillon WP; Weiner MW; Fein G
Neurology; 1993 Mar; 43(3 Pt 1):509-15. PubMed ID: 8450992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
